Last reviewed · How we verify

NCT05041270

Epidural Nalbuphine Versus Dexmedetomidine as Adjuvants to Bupivacaine in Lower Limb Surgeries

Completed NA Last updated 12 May 2023
What this trial tests

NA trial testing normal saline in Lower Limb Surgeries in 23 participants. Completed in 15 May 2022.

Timeline
1 October 2021
Primary endpoint
30 April 2022
15 May 2022

Quick facts

Lead sponsorZagazig University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment23
Start date1 October 2021
Primary completion30 April 2022
Estimated completion15 May 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 21 to 60, any sex, with Lower Limb Surgeries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Combined spinal epidural anesthesia (CSE) with bupivacaine alone is not sufficient to cover pain sequel during lower limb surgeries. Previous studies used addition of either Nalbuphine or dexmedetomidine to bupivacaine in epidural anesthesia giving a good result in pain control. In this study the investigators will evaluate and compare the addition of either Nalbuphine or dexmedetomidine to bupivacaine in epidural anesthesia to evaluate the analgesic efficacy of either drug.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Epidural nalbuphine versus dexmedetomidine as adjuvants to bupivacaine in lower limb orthopedic surgeries for postoperative analgesia: a randomized controlled trial.
    Farmawy MSE, Mowafy SMS, Wahdan RA. · · 2023 · cited 4× · PMID 38057695 · DOI 10.1186/s12871-023-02348-x

Verify or expand the search:

Other trials of normal saline

Trials testing the same drug.

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05041270.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing